USE OF ANTI-IL-19 ANTIBODY IN PREPARAING DRUGS FOR TREATING BREAST CANCER

Research output: Patent

Abstract

本發明係有關於一種抗介白素-19抗體治療乳癌之用途，其可單獨使用、或與抗介白素-20抗體及/或抗介白素-20R1抗體合併使用。

Translated title of the contribution	抗介白素－１９抗體作為製備治療乳癌藥劑之用途
Original language	English
Patent number	I435731
Publication status	Published - 1800

This output contributes to the following UN Sustainable Development Goals (SDGs)

@misc{7db57fe328224607aff83f8eff28033d,

title = "USE OF ANTI-IL-19 ANTIBODY IN PREPARAING DRUGS FOR TREATING BREAST CANCER",

abstract = "本發明係有關於一種抗介白素-19抗體治療乳癌之用途，其可單獨使用、或與抗介白素-20抗體及/或抗介白素-20R1抗體合併使用。",

author = "Ming-Shi Chang",

year = "1800",

language = "English",

type = "Patent",

note = "I435731",

}

TY - PAT

T1 - USE OF ANTI-IL-19 ANTIBODY IN PREPARAING DRUGS FOR TREATING BREAST CANCER

AU - Chang, Ming-Shi

PY - 1800

Y1 - 1800

N2 - 本發明係有關於一種抗介白素-19抗體治療乳癌之用途，其可單獨使用、或與抗介白素-20抗體及/或抗介白素-20R1抗體合併使用。

AB - 本發明係有關於一種抗介白素-19抗體治療乳癌之用途，其可單獨使用、或與抗介白素-20抗體及/或抗介白素-20R1抗體合併使用。

M3 - Patent

M1 - I435731

ER -